📣 VC round data is live. Check it out!

Sudmedica Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sudmedica and similar public comparables like Gesundheitswelt Chiemgau, Maternus-Kliniken, Concord Medical Services, Clinica de Marly and more.

Sudmedica Overview

About Sudmedica

Sudmedica SA is a company brings health care and services to people in those places in Chile where the offer is deficient, with affordable prices for high-standard services. It offers variety of specialities such as Pathological anatomy, Bronchopulmonary, Cardiology Surgery,Head and Neck Surgery,Breast Surgery, Maxillofacial Surgery.


Founded

2017

HQ

Chile

Employees

N/A

Financials (FY)

Revenue: $184K
EBITDA: ($324K)

EV

$37M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sudmedica Financials

Sudmedica reported last fiscal year revenue of $184K and negative EBITDA of ($324K).

In the same fiscal year, Sudmedica generated $32K in gross profit, ($324K) in EBITDA losses, and had net loss of ($297K).


Sudmedica P&L

In the most recent fiscal year, Sudmedica reported revenue of $184K and EBITDA of ($324K).

Sudmedica is unprofitable as of last fiscal year, with gross margin of 17%, EBITDA margin of (176%), and net margin of (161%).

See analyst estimates for Sudmedica
Last FY202320242025202620272028
Revenue$184K$213K$199K$184K
Gross Profit$32K$35K$33K$32K
Gross Margin17%17%17%17%
EBITDA($324K)($653K)($13K)($324K)
EBITDA Margin(176%)(307%)(6%)(176%)
EBIT Margin(178%)(307%)(200%)(178%)
Net Profit($297K)($658K)($92K)($297K)
Net Margin(161%)(309%)(46%)(161%)
Net Debt$7K

Financial data powered by Morningstar, Inc.

Sudmedica Stock Performance

Sudmedica has current market cap of $37M, and enterprise value of $37M.

Market Cap Evolution


Sudmedica's stock price is $1,066.47.

Sudmedica share price increased by 1.5% in the last 30 days, and by 20.9% in the last year.

Sudmedica has an EPS (earnings per share) of $-8.66.

See more trading valuation data for Sudmedica
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$37M$37M-0.0%1.5%-0.7%20.9%$-8.66

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sudmedica Valuation Multiples

Sudmedica trades at 198.8x EV/Revenue multiple, and (113.1x) EV/EBITDA.

See NTM and 2027E valuation multiples for Sudmedica

Sudmedica Financial Valuation Multiples

As of May 10, 2026, Sudmedica has market cap of $37M and EV of $37M.

Sudmedica has a P/E ratio of (123.1x).

Last FY202320242025202620272028
EV/Revenue198.8x171.7x183.7x198.8x
EV/EBITDA(113.1x)(56.0x)n/m(113.1x)
EV/EBIT(111.8x)(55.8x)(91.9x)(111.8x)
EV/Gross Profitn/mn/mn/mn/m
P/E(123.1x)(55.6x)n/m(123.1x)
EV/FCF(92.3x)(66.4x)(59.9x)(92.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sudmedica Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sudmedica Margins & Growth Rates

In the most recent fiscal year, Sudmedica reported gross margin of 17%, EBITDA margin of (176%), and net margin of (161%).

See estimated margins and future growth rates for Sudmedica

Sudmedica Margins

Last FY20242025202720282029
Gross Margin17%17%17%
EBITDA Margin(176%)(6%)(176%)
EBIT Margin(178%)(200%)(178%)
Net Margin(161%)(46%)(161%)
FCF Margin(215%)(307%)(215%)

Sudmedica Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(7%)(8%)
Gross Profit Growth(6%)(5%)
EBITDA Growth(98%)2478%
EBIT Growth(39%)(18%)
Net Profit Growth(86%)222%
FCF Growth11%(35%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Sudmedica Operational KPIs

Access forward-looking KPIs for Sudmedica
Last FY202320242025202620272028
S&M Expenses to Revenue12%0%
G&A Expenses to Revenue43%60%40%43%
Opex to Revenue195%324%216%195%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sudmedica Competitors

Sudmedica competitors include Gesundheitswelt Chiemgau, Maternus-Kliniken, Concord Medical Services, Clinica de Marly, Medcorp, Eukedos, MedNation, Speed Medical SAE, Amwill Healthcare and FamiCord.

Most Sudmedica public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Gesundheitswelt Chiemgau0.5x4.7x
Maternus-Kliniken1.8x18.7x
Concord Medical Services7.6x(48.8x)
Clinica de Marly
Medcorp
Eukedos2.7x12.8x
MedNation0.4x7.2x
Speed Medical SAE

This data is available for Pro users. Sign up to see all Sudmedica competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sudmedica

When was Sudmedica founded?Sudmedica was founded in 2017.
Where is Sudmedica headquartered?Sudmedica is headquartered in Chile.
Is Sudmedica publicly listed?Yes, Sudmedica is a public company listed on Bolsa de Santiago.
What is the stock symbol of Sudmedica?Sudmedica trades under SUDMEDICA ticker.
When did Sudmedica go public?Sudmedica went public in 2024.
Who are competitors of Sudmedica?Sudmedica main competitors include Gesundheitswelt Chiemgau, Maternus-Kliniken, Concord Medical Services, Clinica de Marly, Medcorp, Eukedos, MedNation, Speed Medical SAE, Amwill Healthcare, FamiCord.
What is the current market cap of Sudmedica?Sudmedica's current market cap is $37M.
What is the current revenue of Sudmedica?Sudmedica's last fiscal year revenue is $184K.
What is the current EV/Revenue multiple of Sudmedica?Current revenue multiple of Sudmedica is 198.8x.
Is Sudmedica profitable?No, Sudmedica is not profitable.
How many companies Sudmedica has acquired to date?Sudmedica hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Sudmedica has invested to date?Sudmedica hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sudmedica

Lists including Sudmedica

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial